NEW YORK (GenomeWeb) – Life science company LGC announced today that it has acquired a majority stake in laboratory automation company Douglas Scientific.

Douglas Scientific was previously owned by Kingdom Enterprises, and provides high-throughput PCR and qPCR platforms and Array Tape consumables to applied end markets such as agbio and clinical research laboratories. Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.